Cleared Abbreviated

K032038 - PYRAMIS ECG MANAGEMENT SYSTEM MODEL NUM...

K032038 is the FDA 510(k) clearance for PYRAMIS ECG MANAGEMENT SYSTEM MODEL NUM... by Quinton, Inc.. It is a Class 2 Cardiovascular device (product code DQK) cleared through the Abbreviated 510(k) pathway after a 66-day FDA review.

K032038 · Quinton, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2003
Decision
66d
Days
Class 2
Risk

K032038 is an FDA 510(k) clearance for the PYRAMIS ECG MANAGEMENT SYSTEM MODEL NUMBERS, 92600 AND 92601. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Quinton, Inc. (Bothell, US). The FDA issued a Cleared decision on September 5, 2003 after a review of 66 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Quinton, Inc. devices

Submission Details

510(k) Number K032038 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 01, 2003
Decision Date September 05, 2003
Days to Decision 66 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
59d faster than avg
Panel avg: 125d · This submission: 66d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 259
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K032038.
T-WAVE ALTERNANS (TWA) ALGORITHM OPTION
K032513 · Ge Medical Systems Information Technologies · Oct 2003
MODIFICATION TO: MAC-LAB/CARDIOLAB EP/COMBOLAB SYSTEM
K032577 · Ge Medical Systems Information Technologies · Oct 2003
INFINITY MEGACARE
K031970 · Siemens Medical Solutions USA, Inc. · Sep 2003
CARDIOSOFT/CASE CARDIAC TESTING SYSTEM
K031561 · Ge Medical Systems Information Technologies · Aug 2003
LABSYSTEM III EP LABORATORY W/WINDOWS PLATFORM & WINDOWS EP SOFTWARE VERSION 1.0
K031000 · C.R. Bard, Inc. · Jun 2003
CARTO XP AND QWIKMAP EP NAVIGATION SYSTEM
K020863 · Biosense Webster, Inc. · Jan 2003